Strategies in drug design based on 3D-structures of ligands

Prog Clin Biol Res. 1989:291:177-81.

Authors

Y C Martin¹, E B Danaher, C S May, D Weininger, J H Van Drie

Affiliation

¹ Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064.

PMID: 2726842

No abstract available

MeSH terms

Drug Design*
Information Systems
Ligands*
Models, Molecular
Molecular Conformation*
Software*
Structure-Activity Relationship

Substances

Ligands